Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  filgrastim-primed peripheral blood progenitor cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Nonmyeloablative Donor Stem Cell Transplant in Treating Patients with Congenital Anemias including Sickle Cell Disease and Thalassemia
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 55
Trial IDs: 012013-015, NCI-2014-02134, NCT02038478
Start Over